GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

PPJ Healthcare Enterprises PPJE · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2024

Revenue

$665,694

FY2015FY2024

Net income

$8,101

FY2015FY2024

Free cash flow

$2.4m

FY2015FY2024

Shareholders' equity

$12.6m

FY2015FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Revenue$665,694$711,039$790,556$648,716$305,501$351,890$293,076$406,880$330,882$319,059
Research and development$86,203—$23,900$9,800—$15,000———$6,102
Operating income$8,101$74,728$141,150$143,580$40,160$46,060$4,570−$37,330−$14,902−$28,800
Net income$8,101$74,728$141,150$141,150$40,160$46,063$4,570−$37,327−$14,902−$10.9m
Diluted earnings per share0.000.000.000.000.000.000.00-0.00-0.00-0.27

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Total assets$20.2m$19.0m$18.8m$17.1m$14.2m$13.6m$13.1m$11.9m$2.1m$1.6m
Cash and short-term investments$18,721$49,072$406,901$646,233$42,656$15,272$8,173$7,782$24,222$1,405
Total liabilities$7.6m$7.0m$6.6m$6.2m$6.9m$6.2m$5.7m$4.8m$1.8m$2.3m
Debt$2.6m$2.6m$2.7m$2.6m$2.2m$2.1m$749,238$3.4m$729,238$1.7m
Shareholders' equity$12.6m$12.0m$12.2m$11.0m$7.3m$7.5m$7.4m$7.6m$252,596−$737,060
Shares outstanding9,204m5,505m5,306m5,306m4,841m4,841m8,905m7,661m7,011m40m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operations$2.4m$2.5m$3.0m$13.8m$13.2m$12.7m$12.2m$10.9m$262,068$2.6m
Capital spending−$2——−$4−$3————−$6,102
Free cash flow$2.4m$2.5m$3.0m$13.8m$13.2m$12.7m$12.2m$10.9m$262,068$2.6m

Latest quarters

By quarter end

Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023
Revenue$147,981$161,006$173,659$193,762$137,267$87,535$231,909$227,819
Operating income$22−$32,076−$6,422$35,429$11,170−$89,750$70,670$61,700
Net income$22−$32,076−$6,422$35,429$11,170−$89,749$70,668$61,702
Diluted earnings per share0.00-0.00-0.000.000.00-0.000.000.00
Cash from operations$2.0m−$2.0m—$2.0m$2.0m−$35.0m$18.0m$17.0m
Total assets$20.0m$20.2m$19.8m$19.9m$19.6m$19.0m$19.2m$18.8m
Cash and short-term investments$26,886$18,721$49,923$76,818$56,309$49,072$212,472$248,910
Debt$2.6m$2.6m$2.6m$2.6m$2.6m$2.6m$2.3m$2.7m
Shareholders' equity$24.5m$12.6m$19.2m$12.5m$12.4m$12.0m$12.6m$11.9m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue0.9%13.6%13.8%
Operating income-61.6%-29.4%4.5%
Net income-61.4%-29.4%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin6.0%13.1%13.1%7.6%
Net margin6.0%13.0%13.0%-215.0%

Valuation history

At each fiscal year end

FY2024
Price to earnings0.2

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return6300%68167%71%-44%57%1300%700%0%0%97%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 100-to-1 reverse split · 25 Jul 2016
  • 100-to-1 reverse split · 1 Dec 2014
  • 100-to-1 reverse split · 26 Oct 2011
  • 400-to-1 reverse split · 24 Apr 2008

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.